Case Report

Panhemispheric Infarction: A Complication of Cuffed Catheter

Authors: Mahendra Agraharkar, MD, FACP, Sumita Gokhale, MD, Robert Cinclair, BS, Jignesh Patel, MD, Rajiv Gupta, MD

Abstract

The need for reliable vascular access remains the Achilles heel of hemodialysis. Complications of vascular access are a leading cause of morbidity and mortality in patients who undergo hemodialysis, especially in those patients with end-stage renal disease. Among methods of vascular access, arteriovenous fistulae have the lowest rate of infection and should be the access of choice when vascular anatomy permits. Also, the incidence of staphylococcal infections in patients infected with human immunodeficiency virus is increasing. To emphasize the need to use arteriovenous fistula access for hemodialysis whenever possible, we report the case of a patient with end-stage renal disease and human immunodeficiency virus infection who died as a result of panhemispheric infarction and uncal herniation as a result of fulminant staphylococcal bacteremia caused by central venous catheter sepsis.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Windus DW. Permanent vascular access: A nephrologist's view. Am J Kidney Dis 1993; 21: 457–471.
 
2. Vanherweghem JL, Dhaene M, Goldman M, Stolear JC, Sabot JP, Waterlot Y, et al. Infections associated with subclavian dialysis catheters: The key role of nurse training. Nephron 1986; 42: 116–119.
 
3. Keane WF, Shapiro FL, Raij L. Incidence and type of infections occurring in 445 chronic hemodialysis patients. Trans Am Soc Artif Intern Organs 1977; 23: 41–47.
 
4. Schwarzbeck A, Brittinger WD, Henning GE, Strauch M. Cannulation of subclavian vein for hemodialysis using Seldinger's technique. Trans Am Soc Artif Intern Organs 1978; 24: 27–31.
 
5. Vanholder R, Lameire N, Verbanck J, van Rattinghe R, Kunnen M, Ringoir S. Complications of subclavian catheter hemodialysis: A 5 year prospective study in 257 consecutive patients. Int J Artif Organs 1982; 5: 297–303.
 
6. Uldall PR, Merchant N, Woods F, Yarworski U, Vas S. Changing subclavian haemodialysis cannulas to reduce infection. Lancet 1981; 1: 1373.
 
7. National Kidney Foundation Dialysis Outcomes Quality Initiative. NKF-DOQI clinical practice guidelines for vascular access: National Kidney Foundation Dialysis Outcomes Quality Initiative. Am J Kidney Dis 1997; 30 (4 Suppl 3): S150–S191.
 
8. National Institute of Diabetes and Digestive and Kidney Diseases. Vascular access, in United States Renal Data System (USRDS): 1997 Annual Data Report—Dialysis Morbidity and Mortality (Wave 2). Bethesda, MD, National Institutes of Health, 1997, pp 58–61.
 
9. ESRD Clinical Performance Measures Project. Vascular access: 2000 annual report. Am J Kidney Dis 2001; 37 (1 Suppl 2): S137–S181.
 
10. Robinson DL, Fowler VG, Sexton DJ, Corey RG, Conlon PJ. Bacterial endocarditis in haemodialysis patients. Am J Kidney Dis 1997; 30: 521–524.
 
11. Butterly DW, Schwab SJ. Dialysis access infections. Curr Opin Nephrol Hypertens 2000; 9: 631–635.
 
12. Allon M, Ornt DB, Schwab SJ, Rasmussen C, Delmez JA, Greene T, et al. Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO study: Hemodialysis (HEMO) Study Group. Kidney Int 2000; 58: 2178–2185.
 
13. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520–532.
 
14. Heiro M, Nikoskelainen J, Engblom E, Kotilainen E, Marttila R, Kotilainen P. Neurologic manifestations of infective endocarditis: A 17-year experience in a teaching hospital in Finland. Arch Intern Med 2000; 160: 2781–2787.
 
15. Sandre RM, Shafran SD. Infective endocarditis: Review of 135 cases over 9 years. Clin Infect Dis 1996; 22: 276–286.
 
16. Vlessis AA, Hovaguimian H, Jaggers J, Ahmad A, Starr A. Infective endocarditis: Ten-year review of medical and surgical therapy. Ann Thorac Surg 1996; 61: 1217–1222.
 
17. Rerkpattanapipat P, Wongpraparut N, Jacobs LE, Kotler MN. Cardiac manifestations of acquired immunodeficiency syndrome. Arch Intern Med 2000; 160: 602–608.
 
18. Tunkel AR, Kaye D. Neurologic complications of infective endocarditis. Neurol Clin 1993; 11: 419–440.
 
19. Hurwitz BJ, Posner JB. Cerebral infarction complicating subclavian vein catheterization. Ann Neurol 1977; 1: 253–254.